The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis
Open accessAbstract
Background: Previous reports have suggested that despite their dramatic presentation, patients with fulminant myocarditis (FM) might have better outcome than those with acute nonfulminant myocarditis (NFM). In this retrospective study, we report outcome and changes in left ventricular ejection fraction (LVEF) in a large cohort of patients with FM compared with patients with NFM. Methods: The study population consists of 187 consecutive patients admitted between May 2001 and November 2016 with a diagnosis of acute myocarditis (onset of symptoms <1 month) of whom 55 required inotropes and/or mechanical circulatory support (FM) and the remaining 132 were hemodynamically stable (NFM). We also performed a subanalysis in 130 adult patients with acute viral myocarditis and viral prodrome within 2 weeks from the onset, which includes 34 with FM and 96 with NFM. Patients with giant-cell myocarditis, eosinophilic myocarditis, or cardiac sarcoidosis and those <15 years of age were excluded from the subanalysis. Results: In the whole population (n=187), the rate of in-hospital death or heart transplantation was 25.5% versus 0% in FM versus NFM, respectively ( P <0.0001). Long-term heart transplantation–free survival at 9 years was lower in FM than NFM (64.5% versus 100%, log-rank P <0.0001). Despite greater improvement in LVEF during hospitalization in FM versus NFM forms (median, 32% [interquartile range, 20%–40%] versus 3% [0%–10%], respectively; P <0.0001), the proportion of patients with LVEF <55% at last follow-up was higher in FM versus NFM (29% versus 9%; relative risk, 3.32; 95% confidence interval, 1.45–7.64, P =0.003). Similar results for survival and changes in LVEF in FM versus NFM were observed in the subgroup (n=130) with viral myocarditis. None of the patients with NFM and LVEF ≥55% at discharge had a significant decrease in LVEF at follow-up. Conclusions: Patients with FM have an increased mortality and need for heart transplantation compared with those with NFM. From a functional viewpoint, patients with FM have a more severely impaired LVEF at admission that, despite steep improvement during hospitalization, remains lower than that in patients with NFM at long-term follow-up. These findings also hold true when only the viral forms are considered and are different from previous studies showing better prognosis in FM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel-Aty, H., Gutberlet, M., Prasad, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,509
Stewart, S., Fishbein, M. C., Snell, G. I., Berry, G. J., Boehler, A., Burke, M. M., Glanville, A., Gould, F. K., Magro, C., Marboe, C. C., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.10.017 · Cited by 2,442
Stewart, S., Winters, G. L., Fishbein, M. C., Tazelaar, H. D., Kobashigawa, J., Abrams, J., Andersen, C. B., Angelini, A., Berry, G. J., Burke, M. M., et al. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.03.019 · Cited by 1,799
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis
McCarthy, R. E., Boehmer, J. P., Hruban, R. H., Hutchins, G. M., Kasper, E. K., Hare, J. M., & Baughman, K. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421003 · Cited by 877
Idiopathic Giant-Cell Myocarditis — Natural History and Treatment
Cooper, L. T., Berry, G. J., & Shabetai, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362603 · Cited by 757
Cited by
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811
Self-citationKociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000745 · Cited by 625
Ammirati, E., Cipriani, M., Moro, C., Raineri, C., Pini, D., Sormani, P., Mantovani, R., Varrenti, M., Pedrotti, P., Conca, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035319 · Cited by 452
Self-citation2025 ESC Guidelines for the management of myocarditis and pericarditis
Schulz-Menger, J., Collini, V., Gröschel, J., Adler, Y., Brucato, A., Christian, V., Ferreira, V. M., Gandjbakhch, E., Heidecker, B., Kerneis, M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf192 · Cited by 434
Self-citationDiagnosis and Treatment of Acute Myocarditis: A Review
Ammirati, E., & Moslehi, J. J. (2023) · JAMA · doi:10.1001/jama.2023.3371 · Cited by 379
Self-citationBrambatti, M., Matassini, M. V., Adler, E. D., Klingel, K., Camici, P. G., & Ammirati, E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.023 · Cited by 337
Self-citationAmmirati, E., Veronese, G., Brambatti, M., Merlo, M., Cipriani, M., Potena, L., Sormani, P., Aoki, T., Sugimura, K., Sawamura, A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.063 · Cited by 279
Self-citationManagement of Myocarditis-Related Cardiomyopathy in Adults
Tschöpe, C., Cooper, L. T., Torre-Amione, G., & Van Linthout, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 279
Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis
Ammirati, E., Lupi, L., Palazzini, M., Hendren, N. S., Grodin, J. L., Cannistraci, C. V., Schmidt, M., Hekimian, G., Peretto, G., Bochaton, T., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056817 · Cited by 227
Self-citationMyocarditis in Humans and in Experimental Animal Models
Błyszczuk, P. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00064 · Cited by 161
Ammirati, E., Buono, A., Moroni, F., Gigli, L., Power, J. R., Ciabatti, M., Garascia, A., Adler, E. D., & Pieroni, M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01680-x · Cited by 98
Self-citationBaritussio, A., Schiavo, A., Basso, C., Giordani, A. S., Cheng, C., Pontara, E., Cattini, M. G., Bison, E., Gallo, N., De Gaspari, M., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2496 · Cited by 90
Epidemiology Characteristics and Outcome of Patients With Clinically Diagnosed Acute Myocarditis
Younis, A., Matetzky, S., Mulla, W., Masalha, E., Afel, Y., Chernomordik, F., Fardman, A., Goitein, O., Ben-Zekry, S., Peled, Y., et al. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.10.015 · Cited by 88
Fulminant myocarditis proven by early biopsy and outcomes
Huang, F., Ammirati, E., Ponnaiah, M., Montero, S., Raimbault, V., Abrams, D., Lebreton, G., Pellegrino, V., Ihle, J., Bottiroli, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad707 · Cited by 69
Self-citationKondo, T., Okumura, T., Shibata, N., Imaizumi, T., Dohi, K., Izawa, H., Ohte, N., Amano, T., & Murohara, T. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023719 · Cited by 51
Gentile, P., Merlo, M., Peretto, G., Ammirati, E., Sala, S., Della Bella, P., Aquaro, G. D., Imazio, M., Potena, L., Campodonico, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2288 · Cited by 46
Self-citationEfficacy of immunosuppressive therapy in myocarditis: A 30-year systematic review and meta analysis
Cheng, C.-Y., Cheng, G.-Y., Shan, Z.-G., Baritussio, A., Lorenzoni, G., Tyminska, A., Ozieranski, K., Iliceto, S., Marcolongo, R., Gregori, D., et al. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102710 · Cited by 41
Spatiotemporal transcriptomics elucidates the pathogenesis of fulminant viral myocarditis
Li, H., Chen, X., Wang, J. J., Shen, J., Abuduwufuer, K., Zhang, Z., Dong, Z., Wen, Z., He, J., Chen, S., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02143-9 · Cited by 40
Ozierański, K., Tymińska, A., Kruk, M., Koń, B., Skwarek, A., Opolski, G., & Grabowski, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204672 · Cited by 23
Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art
Campodonico, J., Lauri, C., Pezzuto, B., Agostoni, P., & Vignati, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217661 · Cited by 6
Daoud, A., Kalinoski, H., Talor, M. V., Welsh, R. A., Jo, W., Jaime, C. M., Kolim, B., Mahto, N., Kveton, M., Weislová, I., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf209 · Cited by 4
Metadata
- Authors
- Ammirati, E., Cipriani, M., Lilliu, M., Sormani, P., Varrenti, M., Raineri, C., Petrella, D., Garascia, A., Pedrotti, P., Roghi, A., Bonacina, E., Moreo, A., Bottiroli, M., Gagliardone, M. P., Mondino, M., Ghio, S., Totaro, R., Turazza, F. M., Russo, C. F., Oliva, F., Camici, P. G., & Frigerio, M.
- Venue
- Circulation
- Published
- 2017-08-08
- Volume
- 136
- Issue
- 6
- Pages
- 529-545
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2620651177
- Cited by
- 292
- References
- 36
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.